CIK: 0001937964
Total reported value
$499.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 23.12% | — | +88.68% | |
| 2 | INSM | Insmed INC | Stock-Healthcare | 19.19% | +2.56% | +149.09% | |
| 3 | ARGX | Argenx Se - Adr | Stock-Healthcare | 10.39% | -3.36% | +592.34% | |
| 4 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 9.97% | -3.37% | -32.77% | |
| 5 | LLY | Eli Lilly & Co | Stock-Healthcare | 5.76% | -0.65% | -78.05% | |
| 6 | BSX | Boston Scientific CORP | Stock-Healthcare | 4.01% | — | +19.66% | |
| 7 | ✓ | Merus N V | Stock-Other | 3.76% | — | -30.12% | |
| 8 | DGX | Quest Diagnostics INC | Stock-Healthcare | 3.53% | +0.60% | +44.08% | |
| 9 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 3.21% | -2.48% | EXIT | |
| 10 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 2.00% | — | — | |
| 11 | TRVI | Trevi Therapeutics INC | Stock-Other | 1.73% | +1.24% | — | |
| 12 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.65% | -0.98% | EXIT | |
| 13 | UGL | Proshares Ultra Gold | ETF-Commodities | 1.40% | -4.26% | EXIT | |
| 14 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.35% | — | — | |
| 15 | SRRK | Scholar Rock Holding CORP | Stock-Other | 1.08% | +0.35% | -26.66% | |
| 16 | RVMD | Revolution Medicines INC | Stock-Healthcare | 0.92% | +1.25% | — | |
| 17 | SWTXUSD | Springworks Therapeutics INC | Stock-Other | 0.72% | — | +18.54% | |
| 18 | EYPT | Eyepoint INC | Stock-Other | 0.72% | -0.01% | — | |
| 19 | ABBV | Abbvie INC | Stock-Healthcare | 0.65% | — | — | |
| 20 | VKTX | Viking Therapeutics INC | Stock-Healthcare | 0.62% | -2.41% | +6.87% | |
| 21 | ASND | Ascendis Pharma A/S | Stock-Other | 0.51% | — | +64.52% | |
| 22 | TGTX | Tg Therapeutics INC | Stock-Healthcare | 0.47% | — | — | |
| 23 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 0.47% | — | — | |
| 24 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.37% | — | — | |
| 25 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.35% | +0.24% | — | |
| 26 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.31% | — | +12.82% | |
| 27 | PTGX | Protagonist Therapeutics INC | Stock-Other | 0.31% | +0.20% | -93.13% | |
| 28 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.30% | +0.51% | — | |
| 29 | BHVN | Biohaven Ltd. | Stock-Other | 0.27% | — | — | |
| 30 | RNAGBP | Avidity Biosciences INC | Stock-Other | 0.24% | -0.61% | EXIT | |
| 31 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 0.19% | — | — | |
| 32 | MLYS | Mineralys Therapeutics INC | Stock-Other | 0.13% | +0.04% | — | |
| 33 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 0.12% | +0.73% | — | |
| 34 | JANX | Janux Therapeutics INC | Stock-Other | 0.11% | — | -47.51% | |
| 35 | TVTX | Travere Therapeutics INC | Stock-Other | 0.11% | +0.04% | — |